RT @LuisAlvarezRa: Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephrit…
RT @LuisAlvarezRa: Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephrit…
RT @LuisAlvarezRa: Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephrit…
Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial | BMC Nephrology | Full Text https://t.co/0q7wFis6m3
@GlassockJ @caioqualunque Agree no benefit to adding MMF - realise my tortuous phrasing might not have made that clear. Yes in #lupus, no in primary #membranous. We have shown this in an #RCT https://t.co/4GNU1eONuX @LinaNikolop @megan_griffith1 @Imperial
【RCT】特発性膜性腎症およびネフローゼ症候群の患者へのタクロリムスに対するミコフェノール酸モフェチルの追加は、タクロリムス単剤と比較して、治療中止後の再発率に差はなかった。 https://t.co/LEkIrViy1j